Sanofi | SAN - Interest Income


Sanofi reported EUR77M in Interest Income for its fiscal quarter ending in June of 2026.





Interest Income Change Date
AbbVie USD 67M 5M Jun/2026
Aena EUR -31.86M 63.8M Jun/2026
Almirall EUR 2.71M 580K Dec/2025
Amarin USD 3.37M 3.37M Dec/2024
AstraZeneca USD 80M 7M Jun/2026
Bayer EUR 169M 39M Dec/2025
Biogen USD 25.3M 12.6M Jun/2026
BMW EUR 143M 40M Jun/2026
Eli Lilly USD 65M 25M Sep/2025
Essilor EUR 48M 4M Dec/2024
Fresenius Medical Care EUR 14.7M 77K Jun/2026
Genmab DKK 14M 11M Mar/2026
Gilead Sciences USD 45M 50M Jun/2026
GlaxoSmithKline GBP 58M 36M Jun/2026
GRIFOLS EUR 9.56M 4.5M Jun/2025
Hikma Pharmaceutical USD 4M 0 Dec/2024
J&J USD 0.09 2.18 Sep/2026
Lakefront Biotherapeutics EUR 13.56M 991K Mar/2026
Mercedes-Benz AG EUR 119M 48M Jun/2026
Merck EUR 36M 15M Mar/2026
Merck USD 35M 0 Jun/2026
Pfizer USD 0.56 0.6 Sep/2026
Philips EUR 33M 2M Jun/2026
Regeneron Pharmaceuticals USD 183.3M 200K Jun/2026
Sanofi EUR 77M 17M Jun/2026
Sanofi EUR 77M 17M Jun/2026
SAP EUR 726M 452M Jun/2026